Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GPR160 Antikörper (Intracellular, Loop 2)

Der Kaninchen Polyklonal anti-GPR160 Antikörper wird verwendet zum Nachweis von GPR160 in Proben von Ratte. Er wurde validiert für WB und IHC.
Produktnummer ABIN7886467
1.184,62 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für GPR160 Antikörper (Intracellular, Loop 2) (ABIN7886467)

Target

Alle GPR160 Antikörper anzeigen
GPR160 (G Protein-Coupled Receptor 160 (GPR160))

Reaktivität

  • 35
  • 12
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Ratte

Wirt

  • 36
Kaninchen

Klonalität

  • 36
Polyklonal

Konjugat

  • 24
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser GPR160 Antikörper ist unkonjugiert

Applikation

  • 21
  • 16
  • 11
  • 5
  • 5
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 8
    • 7
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 122-136, Intracellular, Loop 2

    Verwendungszweck

    A Rabbit Polyclonal antibody to GPR160

    Sequenz

    CNLSRATKPS SRWQK

    Homologie

    Mouse - 13 out of 15 amino acid residues identical It won't recognize human samples

    Produktmerkmale

    Anti-GPR160 Antibody (ABIN7581887) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize GPR160 from rat and mouse samples. The antibody will not recognize human GPR160.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    CNLSRATKPSSRWQK, corresponding to amino acid residues 122 - 136 of rat GPR160

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200

    FC: The optimal concentration should be determined by the user

    ICC: The optimal concentration should be determined by the user

    IHC: 1:300

    IP: The optimal concentration should be determined by the user

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Konzentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    GPR160 (G Protein-Coupled Receptor 160 (GPR160))

    Andere Bezeichnung

    GPR160

    Hintergrund

    Synonyms: G-Protein Coupled Receptor 160

    Description: G-protein coupled receptor 160, GP160 or GPR160, is an orphan class A GPCR that plays a role in pain signaling.1,3GPR160 is composed of 338 amino acids, encoded by 7 exons located at 3q26.2-q27, demonstrates a significant degree of conservation across various species, and is expressed in neurons, astrocytes, and microglia within the central nervous system (CNS) and spinal cord.3Cocaine- and amphetamine-regulated transcript peptide (CARTp) exhibits various pharmacological actions in the CNS, peripheral nervous system, and several endocrine organs. It plays a role in reward and addiction, anxiety and depression, and food intake and body weight maintenance. It has been found that the interaction between CARTp and GPR160 is essential for the circadian regulation of appetite and thirst as well as the transmission of pain signals induced by nerve injury. GPR160 has been shown to confer CARTp-induced cFOS and ERK phosphorylation and activation of CREB independently of cAMP signaling. ERK can function as an upstream regulator of CREB phosphorylation during the development of neuropathic pain. As a putative ligand for GPR160, endogenous CARTp inhibition has been shown to mitigate neuropathic pain.1,2GPR160 has also been shown to play a role in the pathogenesis of prostate cancer. Transcription profiles demonstrate a marked increase of GPR160 mRNA in all stages of prostate cancer samples and cancer cell lines, except prostate hyperplasia tissues, with levels comparable to those in stage II-IV cancer patients. GPR160 knockdown increased caspase 1 and IL-6 expression and induced cell cycle arrest and apoptosis. The involvement of GPR160 in prostate carcinogenicity has therapeutic implications for exploring diagnostics and pharmaceutical interventions.3

    Gen-ID

    499588

    UniProt

    Q66H29
Sie sind hier:
Chat with us!